Showing results (161-170 of 228) with videos related to
Sort By:
Pageof 23
The American Journal of Cardiology|April 22, 2005
Effects of atorvastatin versus other statins on fasting and postprandial C-reactive protein and lipoprotein-associated phospholipase A2 in patients with coronary heart disease versus control subjectsErnst J Schaefer, Judith R McNamara, Bela F Asztalos, et al.Atherosclerosis|August 7, 2015
A comparison of glycated albumin and glycosylated hemoglobin for the screening of diabetes mellitus in TaiwanPowen Hsu, Masumi Ai, Eiichiro Kanda, et al.Atherosclerosis|September 22, 2007
Non-invasive detection of aortic and coronary atherosclerosis in homozygous familial hypercholesterolemia by 64 slice multi-detector row computed tomography angiographyRaul D Santos, Marcio H Miname, Lilton R C Martinez, et al.Journal of Lipid Research|September 22, 2010
Common genetic variation in multiple metabolic pathways influences susceptibility to low HDL-cholesterol and coronary heart diseaseGina M Peloso, Serkalem Demissie, Dorothea Collins, et al.Atherosclerosis|September 25, 2010
Direct assessment of plasma low density lipoprotein and high density lipoprotein cholesterol levels and coronary heart disease: results from the Framingham Offspring StudySeiko Otokozawa, Masumi Ai, Bela F Asztalos, et al.Journal of Lipid Research|July 7, 2009
Cholesterol absorption and synthesis markers in individuals with and without a CHD event during pravastatin therapy: insights from the PROSPER trialNirupa R Matthan, Nancy Resteghini, Michele Robertson, et al.Journal of Lipid Research|April 11, 2017
Metabolism and proteomics of large and small dense LDL in combined hyperlipidemia: effects of rosuvastatinNuntakorn Thongtang, Margaret R Diffenderfer, Esther M M Ooi, et al.Atherosclerosis|November 22, 2005
LpA-I, LpA-I:A-II HDL and CHD-risk: The Framingham Offspring Study and the Veterans Affairs HDL Intervention TrialBela F Asztalos, Serkalem Demissie, L Adrienne Cupples, et al.The Journal of Clinical Endocrinology and Metabolism|February 7, 2004
Plasma lipid and lipoprotein levels during the follicular and luteal phases of the menstrual cycleJunaidah B Barnett, Margo N Woods, Stefania Lamon-Fava, et al.Atherosclerosis|May 29, 2009
Marked high density lipoprotein deficiency due to apolipoprotein A-I Tomioka (codon 138 deletion)Masamichi Wada, Tatsuya Iso, Bela F Asztalos, et al.Pageof 23